Uncategorized
Alphaeon acquires Lensar, partners with PhysIOL to commercialize trifocal IOL technology
LAS VEGAS — Alphaeon has entered into a definitive agreement to acquire Lensar for an estimated $59 million in cash, stock and assumed debt, the company announced in a press release. "We’re excited with the chance to join Alphaeon, and together leverage our proprietary platform technology to develop new clinical innovations benefiting physicians and patients alike," Nick Curtis, CEO of Lensar said in the release.